Our CR Strategy
Taking on responsibility
Our corporate responsibility strategy reflects a shared value approach that centers on creating long-lasting added value for both our company and society.
In looking for ways to improve things, we focus our strengths on those areas where we believe we can have the greatest impact:
- Global Health,
- Sustainable Solutions as well as
- Broad Minds.
Our engagement in these areas allows us to be competitive, relevant and pioneering, at the same time as working to secure a sustainable future.
Stronger together with our partners
UN Global Compact
We are a UN Global Compact participant. We commit ourselves to ten principles based on UN conventions regarding human rights, labor standards, environmental protection and anti-corruption. At the same time, the UN Global Compact encourages the signatories to engage in propagating the principles.
As a signatory to the Responsible Care initiative of the chemical industry, we do more than required by law and have adopted binding standards for product responsibility, environmental protection, health and safety.
Together for Sustainability
The Together for Sustainability (TfS) initiative aims to systematically assess and improve sustainability sourcing practices across the globe. The evaluation results can be used by TfS member companies who abide by all restrictions agreed upon within competition law.
Chemie3Corporate Responsibility Report
We are also a member of the Chemie3 initiative. The partners of this unique alliance aim to make sustainability a core part of the chemical industry's guiding principles and to jointly drive the sector's position within the German economy as a key contributor to sustainable development.
The London Declaration is an innovative, multi-stakeholder partnership comprised of pharmaceutical companies, donor groups, implementing partners, governments and other supportive partners committed to attaining the World Health Organization (WHO) 2020 goals.
At the World Economic Forum, 22 leading global pharma companies, including us, announced plans to launch a worldwide initiative called Access Accelerated. It aims to improve the prevention and treatment of non-communicable diseases (NCDs) in low- and middle-income countries.